Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression

Coronavirus disease 2019 (COVID-19), the current global pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Various pharmaceuticals are being developed to counter the spread of the virus. The strategy of repurposing known drugs and bioactive molecules is a rational ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhullar, Khushwant S., Nael, Manal A., Elokely, Khaled M., Drews, Steven J., Wu, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607082/
https://www.ncbi.nlm.nih.gov/pubmed/36297481
http://dx.doi.org/10.3390/pharmaceutics14102045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607082/
https://www.ncbi.nlm.nih.gov/pubmed/36297481
http://dx.doi.org/10.3390/pharmaceutics14102045

Ejemplares similares